9/25/2018 Secemsky: Use of chronic oral anticoagulation and...

- Google Scholar

Triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention: a
viewpoint
JCV Gwyn, MR Thomas… - European Heart Journal …, 2017 - academic.oup.com
Patients undergoing percutaneous coronary intervention (PCI) are treated with dual
antiplatelet therapy to reduce the risk of subsequent myocardial infarction (MI) and stent
thrombosis. Approximately 5–10% of patients undergoing PCI also have atrial fibrillation …
Cited by 4 Related articles All 6 versions

Bleeding in advanced CKD patients on antithrombotic medication–A critical appraisal

A Burlacu, S Genovesi, D Goldsmith, P Rossignol… - Pharmacological …, 2018 - Elsevier
Patients with advanced chronic kidney disease (CKD) are at an increased risk of bleeding,
especially in the context of the complex therapeutic schemes of coronary artery disease
(CAD)(from stable angina to acute coronary syndromes), atrial fibrillation or venous …
Cited by 2 Related articles All 6 versions

Anticoagulant plus antiplatelet therapy for atrial fibrillation

K Bode, G Hindricks, JM Ten Berg, P Whittaker - Herz, 2018 - Springer
Background Emerging evidence indicates combination therapy with anticoagulants and
antiplatelet agents for atrial fibrillation (AF) will be increasingly required. Numerous studies
compare the efficacy and cost-effectiveness of anticoagulation alone in AF, ie, non-vitamin K …
All 3 versions

Triple Therapy: When, if Ever?

N Mihatov, EA Secemsky, S Elmariah - Current treatment options in …, 2018 - Springer
Purpose of review More than 9% of patients who undergo percutaneous coronary
intervention (PCI) carry a concomitant indication for long-term anticoagulation (OAC). The
optimal combination of anticoagulation and antiplatelet therapy for these patients remains …
All 3 versions

Gregory YH Lip (Chair)*, Jean-Phillippe Collet (Co-Chair) 4, Michael Haude (Co-Chair) 5, Robert Byrne 6, 7, Eugene H.
Chung 8, Laurent Fauchier 9, Sigrun …
M Valgimigli, K Huber - academic.oup.com
In 2014, a joint consensus document dealing with the management of antithrombotic therapy
in atrial fibrillation (AF) patients presenting with acute coronary syndrome (ACS) and/or
undergoing percutaneous coronary (PCI) or valve interventions was published, which …

Are Drug Eluting Stents Worth Triple Therapy?

P Heidenreich - 2017 - Am Heart Assoc
Approximately 8% patients undergoing percutaneous coronary intervention are on
anticoagulation, which creates difficult choices regarding stent type and antiplatelet use. 1
Drug eluting stents (DES) are usually preferred over bare metal stents (BMS) because of …
Related articles All 5 versions

https://scholar.google.co.il/scholar?rlz=1C1CHBF_enUS693US694&um=1&ie=UTF-8&lr&cites=6979783247166239103 1/2
9/25/2018 Secemsky: Use of chronic oral anticoagulation and... - Google Scholar

Antithrombotic therapy for patients with an indication for oral anticoagulation undergoing percutaneous coronary
intervention with stent: The case of venous …
L Riva, W Ageno, G Di Pasquale, G Agnelli… - International journal of …, 2018 - Elsevier
The management of antithrombotic therapy in patients on oral anticoagulation (OAC) for
atrial fibrillation (AF) undergoing percutaneous coronary intervention with stent (PCI) is
currently addressed by expert consensus documents and official Guidelines. No specific …
All 5 versions

КОММЕНТАРИИ К ЕВРОПЕЙСКИМ РЕКОМЕНДАЦИЯМ ПО ВЕДЕНИЮ ПАЦИЕНТОВ С ОСТРЫМ ИНФАРКТОМ

МИОКАРДА С ПОДЪЕМОМ СЕГМЕНТА …
АМ Галимжанов - Наука и здравоохранение, 2017 - cyberleninka.ru
В 2017 году были опубликованы обновленные Европейским рекомендациям по
ведению пациентов с острым инфарктом миокарда с подъемом сегмента ST. В статье
были проанализированы все новые и измененные рекомендации в плане возможности …
Related articles All 3 versions

https://scholar.google.co.il/scholar?rlz=1C1CHBF_enUS693US694&um=1&ie=UTF-8&lr&cites=6979783247166239103 2/2